Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Melinta Therapeutics Inc. (MLNT)

4.45 0.35 (8.54%)

09-18 16:00

Open:

4.1

Pre. Close:

4.1

High:

4.525

Low:

4.1

Volume:

362,359

Market Cap:

249M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.532 - 4.559

4.559 - 4.586

Low:

4.04 - 4.07

4.07 - 4.098

Close:

4.401 - 4.448

4.448 - 4.493

Technical analysis  (as of: 2018-09-18 4:37:57 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 5.36     One year: 5.82

Support:

Support1: 3.95    Support2: 3.29

Resistance:

Resistance1: 4.59    Resistance2: 4.98

Pivot:

4.45

Moving Averages:

MA(5): 4.31     MA(20): 4.51

MA(100): 6.11     MA(250): 10.29

MACD:

MACD(12,26): -0.21     Signal(12,26,9): -0.24

%K %D:

%K(14,3): 25.05     %D(3): 17.97

RSI:

RSI(14): 44.86

52-Week:

High: 18.2  Low: 3.95  Change(%): -71.7

Average Vol(K):

3-Month: 38036  10-Days 35626

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
MLNT has closed above bottom band by 49.7%. Bollinger Bands are 58.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to MLNT's normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-09-18T09:06:26-04:00
Melinta Therapeutics names Peter Milligan as Chief Financial Officer

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

56.01

Shares Float (M)

54.86

% Held by Insiders

% Held by Institutions

62.40

Shares Short (K)

1302

Shares Short Prior Month (K)

Stock Financials

EPS

-3.810

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

-3.757

Book Value (p.s.)

0.930

PEG Ratio

-0.01

Profit Margin

Operating Margin

-369.09

Return on Assets (ttm)

-37.0

Return on Equity (ttm)

-63.1

Qtrly Rev. Growth

202.1

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.181

Qtrly Earnings Growth

Operating Cash Flow (M)

-166.91

Levered Free Cash Flow (M)

-56.22

Valuation

P/E

-1.17

P/E Growth Ratio

0.09

P/BV

4.78

P/S

155777808.00

P/CF

-1.49

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-11-06

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.